Surfactant as a drug carrier.

Semin Fetal Neonatal Med

Newborn Research, The Royal Women's Hospital, Melbourne, Australia; Department of Obstetrics, Gynaecology and Newborn Health, The University of Melbourne, Melbourne, Australia; Neonatal Research, Murdoch Children's Research Institute, Melbourne, Australia.

Published: December 2023

Drug delivery using a surfactant vehicle has the potential to prevent systemic side effects by delivering therapeutic agents directly to the respiratory system. The inherent chemical properties of surfactant allows it to readily distribute throughout the respiratory system. Therapeutic agents delivered by surfactant can primarily confer additional benefits but have potential to improve surfactant function. It is critically important that additional agents do not interefere with the innate surface tension lowering function of surfactant. Systemic evaluation through benchtop, translational and human trials are required to translate this potential technique into clinical practice.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.siny.2023.101499DOI Listing

Publication Analysis

Top Keywords

therapeutic agents
8
respiratory system
8
surfactant
6
surfactant drug
4
drug carrier
4
carrier drug
4
drug delivery
4
delivery surfactant
4
surfactant vehicle
4
vehicle potential
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!